Paeds SAQs · endocrinology-diabetes-and-growth
Short stature and poor linear growth — formative SAQs
Formative SAQs on the diagnostic approach to the short child, the GH-IGF-1 axis and the distinction of variants from pathology.
On this page
Study tools
Target exams
SAQ 1 (10)
A 6-year-old boy is referred because he is the smallest in his class. His height is at the 3rd centile and has tracked parallel to that centile over 18 months. Both parents are short. Examination is normal, with a normal upper-to-lower segment ratio. Bone age matches chronological age. [2]
- Define short stature and state why growth velocity matters more than a single measurement. (3) [2] [5]
- List four features that support a normal variant (familial short stature) rather than pathological short stature. (4) [2]
- Outline how you would calculate the mid-parental (target) height and interpret the result. (3) [6]
Model answer
Definition and velocity. Short stature is height more than two standard deviations below the mean for age and sex (about the 3rd centile). Growth velocity — the rate of change over serial measurements — matters more than a single point because a child tracking a low parallel channel is usually a healthy variant, whereas downward centile crossing is pathology until proven otherwise. [2] [5]
Familial short stature features. Short parents with a mid-parental height consistent with the current channel; normal height velocity tracking parallel to the centiles; normal examination including a normal upper-to-lower segment ratio and normal puberty; and a bone age that matches chronological age. Together these support a normal variant rather than disease. [2]
Mid-parental height. Using the Tanner approach, the target for a boy is the average of the parental heights plus 6.5 cm, and for a girl the average minus 6.5 cm, with a corridor of about ±10 cm. The child is expected to track within this corridor; a height far below it warrants investigation even if the centile looks normal. The formula is imprecise at the extremes, so use it as a corridor rather than a prediction. [6]
References6ShowHide
- [1]Cohen P, Rogol AD, Deal CL, et al Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. The Journal of Clinical Endocrinology and Metabolism, 2008.PMID 18782877
- [2]Barstow C, Rerucha C Evaluation of Short and Tall Stature in Children. American Family Physician, 2015.PMID 26132126
- [3]Growth Hormone Research Society Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. The Journal of Clinical Endocrinology and Metabolism, 2000.PMID 11095419
- [4]Murray PG, Dattani MT, Clayton PE Controversies in the diagnosis and management of growth hormone deficiency in childhood and adolescence. Archives of Disease in Childhood, 2016.PMID 26153506
- [5]Wit JM, Clayton PE, Rogol AD, et al Idiopathic short stature: definition, epidemiology, and diagnostic evaluation. Growth Hormone & IGF Research, 2008.PMID 18182313
- [6]Ciancia S, Cajas PR, Cools M How accurate is Tanner's formula in estimating target height? BMC Pediatrics, 2025.PMID 41350675